LUSUTROMBOPAG | LUSUTROMBOPAG | ATC B02BX07
BLOOD THROMBOPOIETIN RECEPTOR (TPO) AGONIST TREATMENT OF THROMBOCYTOPENIA | ORAL | Cmax 187.7 NANOMOLAR Tmax 7 HOUR VD 39.5 LITER PPB 99.9 PERCENT Cl 1.1 LITER / HOUR HT 27 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | THROMBOPOIETIN RECEPTOR | Thrombopoietin receptor UNIPROT P40238 MPL more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |